The title of our recent paper should be corrected. The title should be changed from “Marcromolecular Architecture and Encapsulation of the Anticancer Drug Everolimus Control the Self-Assembly of Amphiphilic Polypeptide-Containing Hybrids” to “Macromolecular Architecture and Encapsulation of the Anticancer Drug Everolimus Control the Self-Assembly of Amphiphilic Polypeptide-Containing Hybrids”. The Supporting Information was also changed to account for the correction of the title. The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.biomac.0c00236.

• (PDF)

(PDF) Electronic Supporting Information files are available without a subscription to ACS Web Editions. The American Chemical Society holds a copyright ownership interest in any copyrightable Supporting Information. Files available from the ACS website may be downloaded for personal use only. Users are not otherwise permitted to reproduce, republish, redistribute, or sell any Supporting Information from the ACS website, either in whole or in part, in either machine-readable form or any other form without permission from the American Chemical Society. For permission to reproduce, republish and redistribute this material, requesters must process their own requests via the RightsLink permission system. Information about how to use the RightsLink permission system can be found at http://pubs.acs.org/page/copyright/permissions.html. This article has not yet been cited by other publications. The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.biomac.0c00236.

• (PDF)

(PDF) Electronic Supporting Information files are available without a subscription to ACS Web Editions. The American Chemical Society holds a copyright ownership interest in any copyrightable Supporting Information. Files available from the ACS website may be downloaded for personal use only. Users are not otherwise permitted to reproduce, republish, redistribute, or sell any Supporting Information from the ACS website, either in whole or in part, in either machine-readable form or any other form without permission from the American Chemical Society. For permission to reproduce, republish and redistribute this material, requesters must process their own requests via the RightsLink permission system. Information about how to use the RightsLink permission system can be found at http://pubs.acs.org/page/copyright/permissions.html.

中文翻译：

---

对“大分子结构和抗癌药物依维莫司的包封控制两亲性多肽杂化物的自组装”的更正。

我们最近的论文的标题应该被更正。标题应从“包含两亲多肽的杂化物的自组装的抗癌药物依维莫司的大分子体系结构和封装”更改为“包含两亲多肽的杂化剂的自组装”的大分子结构和封装。 ”。支持信息也进行了更改，以说明标题的更正。可从https://pubs.acs.org/doi/10.1021/acs.biomac.0c00236免费获得支持信息。

• （PDF）

（PDF）无需订阅ACS Web版本即可获得电子支持信息文件。美国化学学会在任何可版权保护的支持信息中拥有版权权益。ACS网站上提供的文件只能下载供个人使用。未经美国化学学会许可，不得以其他方式允许用户以机器可读形式或任何其他形式全部或部分复制，重新发布，重新分发或出售ACS网站上的任何支持信息。为了获得复制，重新发布和重新分发此材料的许可，请求者必须通过RightsLink许可系统处理自己的请求。有关如何使用RightsLink权限系统的信息，请访问http://pubs.acs.org/page/copyright/permissions.html。本文尚未被其他出版物引用。可从https://pubs.acs.org/doi/10.1021/acs.biomac.0c00236免费获得支持信息。

• （PDF）

（PDF）无需订阅ACS Web版本即可获得电子支持信息文件。美国化学学会在任何可版权保护的支持信息中均拥有版权权益。ACS网站上提供的文件只能下载供个人使用。未经美国化学学会许可，不得以其他方式允许用户以机器可读形式或任何其他形式全部或部分复制，重新发布，重新分发或出售ACS网站上的任何支持信息。为了获得复制，重新发布和重新分发此材料的许可，请求者必须通过RightsLink许可系统处理自己的请求。有关如何使用RightsLink权限系统的信息，请访问http://pubs.acs.org/page/copyright/permissions.html。